| |
| |
|
| Insider
Information: |
Farwell Wildon |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
150,560 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,833,258 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
150,560 |
|
|
| Total
Value |
$3,833,258 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-12 |
150,560 |
2021-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-03-12 |
4 |
AS |
$25.58 |
$26,347 |
D/D |
(1,030) |
150,560 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-03-11 |
4 |
AS |
$25.70 |
$40,735 |
D/D |
(1,585) |
151,590 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-03-07 |
4 |
AS |
$25.80 |
$256,585 |
D/D |
(9,921) |
153,175 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-28 |
4 |
AS |
$25.00 |
$10,175 |
D/D |
(407) |
163,096 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-02-12 |
4 |
AS |
$25.07 |
$137,710 |
D/D |
(5,493) |
163,503 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2024-01-26 |
4 |
AS |
$25.00 |
$2,500 |
D/D |
(100) |
168,996 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-12-12 |
4 |
AS |
$10.55 |
$10,318 |
D/D |
(978) |
169,096 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-12-11 |
4 |
AS |
$10.72 |
$18,095 |
D/D |
(1,688) |
170,074 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
82,512 |
171,762 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-09-12 |
4 |
AS |
$10.41 |
$17,770 |
D/D |
(1,707) |
89,250 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-06-13 |
4 |
AS |
$12.43 |
$21,106 |
D/D |
(1,698) |
90,957 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-12-12 |
4 |
AS |
$10.87 |
$6,826 |
D/D |
(628) |
100,096 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
100,724 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-09-15 |
4 |
D |
$14.05 |
$9,245 |
D/D |
(658) |
64,724 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-06-14 |
4 |
D |
$4.95 |
$3,307 |
D/D |
(668) |
65,382 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-03-11 |
4 |
AS |
$8.73 |
$5,587 |
D/D |
(640) |
66,050 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-03-02 |
4 |
AS |
$8.56 |
$48,082 |
D/D |
(5,617) |
66,690 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,307 |
72,307 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
